Efficacy and Safety of BG00012 in MS
NCT00168701
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
260
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Sclerosis
Interventions
DRUG:
BG00012
Sponsor
Biogen